KŘIKAVA, Ivo, Martin KOLAR, Barbora GARAJOVA, Tomas BALIK, Alena ŠEVČÍKOVÁ, Ingolf ROSCHKE and Pavel SEVCIK. The efficacy of a non-leaching antibacterial central venous catheter - a prospective, randomized, double-blind study. Biomedical Papers, Olomouc: Palacky University. Olomouc: Palacky University, 2020, vol. 164, No 2, p. 154-160. ISSN 1213-8118. Available from: https://dx.doi.org/10.5507/bp.2019.022.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The efficacy of a non-leaching antibacterial central venous catheter - a prospective, randomized, double-blind study
Authors KŘIKAVA, Ivo (203 Czech Republic, belonging to the institution), Martin KOLAR (203 Czech Republic), Barbora GARAJOVA (203 Czech Republic), Tomas BALIK (203 Czech Republic), Alena ŠEVČÍKOVÁ (203 Czech Republic, belonging to the institution), Ingolf ROSCHKE (276 Germany) and Pavel SEVCIK (203 Czech Republic, guarantor).
Edition Biomedical Papers, Olomouc: Palacky University, Olomouc, Palacky University, 2020, 1213-8118.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30223 Anaesthesiology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.245
RIV identification code RIV/00216224:14110/20:00116005
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.5507/bp.2019.022
UT WoS 000542635800006
Keywords in English antimicrobial; CVC; non-leaching; catheter-related bloodstream infections
Tags 14110322, 14110616, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 16/7/2020 10:42.
Abstract
Background. Antimicrobial coatings of central venous catheters (CVC) have the potential to reduce the risk of infectious complications. The aim of this study was to examine the efficacy of a catheter with a non-leaching antimicrobial coating against catheter colonization and bloodstream infections (BSI). Methods. The study was conducted in two centers using a prospective, randomized, double-blind and controlled design (680 intensive care patients; a protective CVC (Certofix (R) protect) or a standard CVC (Certofix (R)). Primary objectives were the rates of catheter colonization and BSI in the two groups. Other baseline demographics, APACHE II score, insertion site, location of CVC placement (ICU or theatre), indwelling time and length of ICU stay were comparable for both groups. Results. While the rate of catheter colonization between the coated and uncoated CVC (17.4% vs. 18.7%, P=0.7477) and the rate of microbiologically confirmed catheter associated infections were similar (1.4% vs. 1.9%, P=0.7521), the coated CVC showed a significantly lower incidence of BSI (2.0% vs. 6.5%, P=0.0081) and a significantly lower mean incidence of BSI per 1000 catheter days (3.2 vs. 8.3, P=0.0356). Conclusion. The non-leaching antibacterial coating of the protective catheter was effective in reducing the incidence of BSI but not the rate of catheter colonization. However, the incidence of BSI is a better surrogate marker for the risk of developing clinical signs of infection suggesting that use of the non-leaching protective catheter is effective in this regard.
PrintDisplayed: 22/7/2024 12:31